


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 1 Nov 2011
Conatus Pharmaceuticals Appoints Dr. Gary Burgess as Senior Vice President and Chief Medical Officer
Conatus Pharmaceuticals Appoints Dr. Gary Burgess as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 31 Oct 2011
Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern
Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern
HSMN NewsFeed - 31 Oct 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
HSMN NewsFeed - 26 Oct 2011
Mylan Announces New, Expanded Management Structure to be Effective Jan. 1, 2012
Mylan Announces New, Expanded Management Structure to be Effective Jan. 1, 2012
HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 11 Oct 2011
Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
HSMN NewsFeed - 4 Oct 2011
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
HSMN NewsFeed - 3 Oct 2011
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
HSMN NewsFeed - 28 Sep 2011
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
HSMN NewsFeed - 26 Sep 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
HSMN NewsFeed - 15 Sep 2011
Curis, Inc. Announces Appointment of Robert Martell, M.D., Ph.D. to its Board of Directors
Curis, Inc. Announces Appointment of Robert Martell, M.D., Ph.D. to its Board of Directors
HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
HSMN NewsFeed - 14 Sep 2011
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
HSMN NewsFeed - 13 Sep 2011
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
HSMN NewsFeed - 13 Sep 2011
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
HSMN NewsFeed - 13 Sep 2011
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
HSMN NewsFeed - 13 Sep 2011
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
HSMN NewsFeed - 12 Sep 2011
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
HSMN NewsFeed - 12 Sep 2011
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
HSMN NewsFeed - 8 Sep 2011
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
